| Literature DB >> 36131726 |
Weiyang Wang1,2, Ruixi Ye1,2, Wenqing Xie1,3, Yueyao Zhang1,2, Senbo An4, Yusheng Li1,3, Yang Zhou5.
Abstract
Sandwiched between articular cartilage and subchondral bone, the calcified cartilage layer (CCL) takes on both biomechanical and biochemical functions in joint development and ordinary activities. The formation of CCL is not only unique in articular cartilage but can also be found in the chondro-osseous junction adjacent to the growth plate during adolescence. The formation of CCL is an active process under both cellular regulation and intercellular communication. Abnormal alterations of CCL can be indications of degenerative diseases including osteoarthritis. Owing to the limited self-repair capability of articular cartilage and core status of CCL in microenvironment maintenance, tissue engineering reconstruction of CCL in damaged cartilage can be of great significance. This review focuses on possible tissue engineering reconstruction methods targeting CCL for further OA treatment.Entities:
Keywords: calcified cartilage layer; engineering reconstruction; osteoarthritis; scaffolds; tidemark
Year: 2022 PMID: 36131726 PMCID: PMC9483725 DOI: 10.3389/fbioe.2022.911281
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1Origin and development of CCL and the growth plate. (1) Secondary ossification centers have formed. The initial structure of articular cartilage and growth plate comes from the same cartilaginous tissue. (2) Osteoblasts invade the lower boundary of the growth plate, replacing the cartilage with a bone; at the same rate, the growth plate enlarges through interstitial growth at the upper boundary by chondrocyte division and enlargement. The epiphysis is pushed away from the diaphysis, and the bone length increases. In contrast, the height of the calcified cartilage layer is maintained by the balance between tidemark advancement and bone transformation. (3) Following epiphyseal closure in adolescence, the calcified cartilage layer remains quiescent but can be reactivated in the ageing process and OA. (4) Microscopic three-dimensional structure of CCL.
CCL and subchondral bone changes during early and late stages of OA.
| CCL | Subchondral bone plate | Subchondral cancellous bone | Overall remodeling condition | |
|---|---|---|---|---|
| Early stage of OA | Thinner | Thinner | (The trabecular plate) Thinner and more rod-like | ↑Remodeling + osteopenia |
| Late stage of OA | Thicken | Thicken | Osteopenic | ↓Remodeling + sclerosis |
FIGURE 2CCL in normal and OA joints with the progression of OA, tidemark advances, and calcified cartilage layer gets thicker, while noncalcified articular cartilage attenuates. Under repetitive stress, microcracks in the calcified cartilage layer take place, which promotes vascular invasion and associated repairing mechanisms. Moreover, sclerosis of both the subchondral plate and calcified cartilage aggravates too.
Changes of CCL and subchondral bone in different levels in OA progression.
| CCL | Bone | |
|---|---|---|
| Gross morphology | Enhanced vascularization, | |
| Microstructure | Multiple tidemarks, | Subchondral sclerosis, |
| Thinner/thicker CCL, | ↑Number and size of natural holes, | |
| Microcracks, | Microcracks (cortical end plate), | |
| Porosity | ↑ | |
| Composition, | ↓Collagen | NA |
| ↓Proteoglycan | ||
| ↑Mineral | ||
| Material properties | ↓Stiffness, | |
| Cellular properties | Hypertrophic chondrocytes, | |
CCL regeneration strategies.
| Strategy | |
|---|---|
| Conventional strategies | Subchondral drilling |
| Microfracture | |
| Allograft implantation | Autologous chondrocyte implantation |
| Matrix-associated ACI | |
| Autologous and allogeneic osteochondral transplantation | |
| OTE and CTE cell-based strategies | Digestion reagent-based strategies |
| Chemotactic agent-based strategies | |
| Biomaterial-based strategies | |
| OTE and CTE scaffold-based strategies | (Chemically modified) Scaffold (mostly hydrogels) |
| Multi-phased layer scaffold | |
| Growth factor-induced BMSCs/scaffold | |
| Novel designed scaffold (3D printing) |
OTE, osteochondral tissue engineering; CTE, cartilage tissue engineering.
Methods of CCL regeneration.
| Type of strategy | Researcher | Time | Experimental model | Material | Reference |
|---|---|---|---|---|---|
| Scaffold-based | Petrovova E | 2021 | Sheep | Porous acellular PHB/CHIT-based scaffold |
|
| Liu M | 2021 | Rabbit | PLCL-based tri-layered fibrous membranes |
| |
| Cai H | 2020 | Rabbit | Injectable tissue-induced Col I hydrogel and BMSCs |
| |
| Kosik-Kozioł A | 2019 |
| Alginate, gelatin MAM, and β-TCP particles and BMSCs |
| |
| You F | 2018 | Mouse | Porous ALG/HAP hydrogel |
| |
| Yang J | 2018 | Rabbit | Ica-HA/Col hydrogel and BMSCs |
| |
| Li Z | 2018 |
| PLGA, HA, and extracted bovine cartilage matrix |
| |
| Khanarian NT | 2012 |
| HA and alginate hydrogel |
| |
| Cheng HW | 2011 |
| Collagen and BMSCs (BMSC-collagen microspheres) |
| |
| Jiang J | 2010 |
| Agarose hydrogel and PLGA/45S5 bioactive glass |
| |
| Cell-based | Allan KS | 2007 |
| DZCs, porous CPP, and β-GP |
|
| Kandel R | 1999 |
| Interface-relevant DZCs, Col II, and mineralization media (β-GP, PEA, and ATP) |
|
(a) PHB/CHIT, polyhydroxybutyrate/chitosan; (b) PLCL, poly(L-lactide-co-caprolactone); (c) Col I, type I collagen; (d) BMSCs, bone marrow mesenchymal stem cells; (e) MAM, methacrylamide; (f) β-TCP, β-tricalcium phosphate; (g), ALG/HAP: alginate/hydroxyapatite; (h) Ica-HA/Col, icariin-conjugated hyaluronic acid/collagen; (i) PLGA, polylactic-co-glycolic acid; (j) HA, hydroxyapatite; (k) DZCs, deep zone chondrocytes; (l) CPP, calcium polyphosphate; (m) β-GP, β-glycerophosphate; (n) Col II, type II collagen; (o) PEA, phosphoethanolamine; (p) ATP, adenosine triphosphate.